All News #Library
Biotech
XOMA Royalty Completes Acquisition Of Mural Oncology
05 Dec 2025 //
GLOBENEWSWIRE
Mural Agrees to Xoma Buyout After Being Cornered
20 Aug 2025 //
FIERCE BIOTECH
Mural Oncology to be Acquired by XRA 5, XOMA Royalty Subsidiary
20 Aug 2025 //
GLOBENEWSWIRE
Mural Oncology Announces Q2 Financial Results and Updates
04 Aug 2025 //
GLOBENEWSWIRE
Mural Updates Ph III Nemvaleukin, Keytruda Trial In Ovarian Cancer
25 Mar 2025 //
GLOBENEWSWIRE
Mural Oncology Report Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Dec 2024 //
GLOBENEWSWIRE
Mural Oncology Reports Inducement Grants Under Nasdaq
04 Sep 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support